Sin3B loss reshapes the tumor microenvironment, leading to increased infiltration as well as cytotoxicity of CD8+ T cells, to impede PDAC progression and enhance sensitivity to anti‐PD1 treatment. The gene discussed is CD8A; the disease is neoplasm.